TrialIntensive care medicine2024

Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).

Peter Pickkers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.